Unmasking insulinoma following commencement of somatostatin analogues in malignant neuroendocrine tumours
{{output}}
Objective: Somatostatin analogues (SSA) are used in the management of patients with metastatic gastroenteropancreatic neuroendocrine tumours (GEP-NET) to control hormone secretion and tumour growth. SSA can paradoxically worsen o... ...
